AbbVie Contract Manufacturing AbbVie Contract Manufacturing

X

CAS 619-65-8 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 619-65-8
Also known as: 619-65-8, P-cyanobenzoic acid, Benzoic acid, 4-cyano-, P-carboxybenzonitrile, Benzoic acid, p-cyano-, 4-carboxybenzonitrile
Molecular Formula
C8H5NO2
Molecular Weight
147.13  g/mol
InChI Key
ADCUEPOHPCPMCE-UHFFFAOYSA-N
FDA UNII
50Z9A3423Z

1 2D Structure

CAS 619-65-8

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
4-cyanobenzoic acid
2.1.2 InChI
InChI=1S/C8H5NO2/c9-5-6-1-3-7(4-2-6)8(10)11/h1-4H,(H,10,11)
2.1.3 InChI Key
ADCUEPOHPCPMCE-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1=CC(=CC=C1C#N)C(=O)O
2.2 Other Identifiers
2.2.1 UNII
50Z9A3423Z
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 4-cyanobenzoate

2. P-cyanobenzoic Acid

2.3.2 Depositor-Supplied Synonyms

1. 619-65-8

2. P-cyanobenzoic Acid

3. Benzoic Acid, 4-cyano-

4. P-carboxybenzonitrile

5. Benzoic Acid, P-cyano-

6. 4-carboxybenzonitrile

7. 4-cyano-benzoic Acid

8. Terephthalic Acid Mononitrile

9. Mfcd00002528

10. 4-cyano Benzoic Acid

11. Nsc-6306

12. 50z9a3423z

13. 4-cyanobenzoicacid

14. Benzoicacid, 4-cyano-

15. Unii-50z9a3423z

16. Nsc 6306

17. Einecs 210-606-9

18. Para-cyanobenzoic Acid

19. Terephthalic Mononitrile

20. 4-cyanobenzoic Acid (3)

21. 4-cyanobenzoic Acid, 99%

22. Dsstox_cid_21659

23. Dsstox_rid_79806

24. Dsstox_gsid_41659

25. Cyanobenzoic Acid, P-

26. Schembl216706

27. Cyanobenzoic Acid, 4-

28. Chembl101772

29. Dtxsid9041659

30. Nsc6306

31. Bdbm239164

32. Zinc331775

33. Bcp28910

34. Str03453

35. Tox21_302120

36. Ck2166

37. Stl164357

38. Akos000119707

39. Ac-2506

40. Ps-4038

41. Ncgc00255602-01

42. Bp-11677

43. Cas-619-65-8

44. Db-054033

45. Am20050235

46. Ft-0618298

47. 619c658

48. Ac-907/25014365

49. W-105067

50. Q27260843

51. F2191-0086

52. P-cyanobenzoic Acid;benzoic Acid, 4-cyano-;p-carboxybenzonitrile

2.4 Create Date
2005-03-26
3 Chemical and Physical Properties
Molecular Weight 147.13 g/mol
Molecular Formula C8H5NO2
XLogP31.6
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count3
Rotatable Bond Count1
Exact Mass147.032028402 g/mol
Monoisotopic Mass147.032028402 g/mol
Topological Polar Surface Area61.1 Ų
Heavy Atom Count11
Formal Charge0
Complexity195
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag India
Digital Content Digital Content
1072-98-6
Betrixaban Maleate
Aptra Synthesis Private Limited, is a reliable and vertically integrated manufacturer of APIs and interme...
Aptra Synthesis Private Limited, is a reliable and vertically integrated manufacturer of APIs and intermediates, boasting state-of-the-art manufacturing facilities that adhere to GMP standards. We take great pride in producing top-notch intermediates through our fully backward-integrated process. Aptra Synthesis Private Limited (ASPL) stands as one of the rapidly emerging manufacturers of Active Pharmaceutical Ingredients (APIs), Pellets (Semi-finished Formulations), and Intermediates.
Aptra Synthesis

78th STLE Annual Meeting

Not Confirmed

envelop Contact Supplier
Flag China
Digital Content Digital Content
URL Supplier Web Content
1882-69-5
Betrixaban Maleate
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary locat...
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technological Development Zone,Cangzhou City,Hebei Province. Senary cover an area of 67,000 square meters, and 300 professionals work there. Senary R&D organization recognized as the Hebei Provincial Engineering Technology Center is comprised of two R & D centers in Tianjin and Cangzhou, and it employs 80 experienced scientists in total. Senary focus on the development, production and sales of advanced pharmaceutical intermediates. Especially, Senary has leading technology and manufacturing capacity for diabetes drug intermediates. All intermediates of DPP4 and SGLT2 class drugs on market have been commercialized production. Senary has 150 sets of 50 ~ 8000L reactor with annual production capacity of 1,000 tons, which can handle both low and high temperature reactions within -100 ~ 240 ℃ range, all kinds of catalytic reactions within 0 ~ 5MPa pressure, and moisture and/or oxygen sensitive reactions. Senary also has expertise in chiral synthesis with leading technologies. The advanced sewage treatment system at Senery has processing capacity of 600 tons daily. Senary has an excellent team that has rich quality management experience.We have established a set of normative and perfect quality managment system,monitoring the whole process of risk assessment,R&D,transfer from pilot scale to commercial production,manufacturing,analysis and sales service. Senary will continue to dedicate on the field of pharmaceutical intermediates to provide the best service for domestic and foreign API pharmaceutical companies with high quality and timely supply of products.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
280773-17-3
Betrixaban Maleate
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary locat...
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technological Development Zone,Cangzhou City,Hebei Province. Senary cover an area of 67,000 square meters, and 300 professionals work there. Senary R&D organization recognized as the Hebei Provincial Engineering Technology Center is comprised of two R & D centers in Tianjin and Cangzhou, and it employs 80 experienced scientists in total. Senary focus on the development, production and sales of advanced pharmaceutical intermediates. Especially, Senary has leading technology and manufacturing capacity for diabetes drug intermediates. All intermediates of DPP4 and SGLT2 class drugs on market have been commercialized production. Senary has 150 sets of 50 ~ 8000L reactor with annual production capacity of 1,000 tons, which can handle both low and high temperature reactions within -100 ~ 240 ℃ range, all kinds of catalytic reactions within 0 ~ 5MPa pressure, and moisture and/or oxygen sensitive reactions. Senary also has expertise in chiral synthesis with leading technologies. The advanced sewage treatment system at Senery has processing capacity of 600 tons daily. Senary has an excellent team that has rich quality management experience.We have established a set of normative and perfect quality managment system,monitoring the whole process of risk assessment,R&D,transfer from pilot scale to commercial production,manufacturing,analysis and sales service. Senary will continue to dedicate on the field of pharmaceutical intermediates to provide the best service for domestic and foreign API pharmaceutical companies with high quality and timely supply of products.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
1072-98-6
Betrixaban Maleate
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary locat...
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technological Development Zone,Cangzhou City,Hebei Province. Senary cover an area of 67,000 square meters, and 300 professionals work there. Senary R&D organization recognized as the Hebei Provincial Engineering Technology Center is comprised of two R & D centers in Tianjin and Cangzhou, and it employs 80 experienced scientists in total. Senary focus on the development, production and sales of advanced pharmaceutical intermediates. Especially, Senary has leading technology and manufacturing capacity for diabetes drug intermediates. All intermediates of DPP4 and SGLT2 class drugs on market have been commercialized production. Senary has 150 sets of 50 ~ 8000L reactor with annual production capacity of 1,000 tons, which can handle both low and high temperature reactions within -100 ~ 240 ℃ range, all kinds of catalytic reactions within 0 ~ 5MPa pressure, and moisture and/or oxygen sensitive reactions. Senary also has expertise in chiral synthesis with leading technologies. The advanced sewage treatment system at Senery has processing capacity of 600 tons daily. Senary has an excellent team that has rich quality management experience.We have established a set of normative and perfect quality managment system,monitoring the whole process of risk assessment,R&D,transfer from pilot scale to commercial production,manufacturing,analysis and sales service. Senary will continue to dedicate on the field of pharmaceutical intermediates to provide the best service for domestic and foreign API pharmaceutical companies with high quality and timely supply of products.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content

4- Cyanobenzoyl chloride

URL Supplier Web Content
6068-72-0
Betrixaban Maleate
Established in 2011 and situated in Hangzhou, Zhejiang, China, Hangzhou Longshine Bio-Tech CO., Ltd is de...
Established in 2011 and situated in Hangzhou, Zhejiang, China, Hangzhou Longshine Bio-Tech CO., Ltd is dedicated to providing services for pharmaceutical and chemical products, catering to both export and import markets. The company consists of two primary business departments: the Professional Sourcing/Product Team and the Quality Team. Backed by experienced partners, Longshine has evolved into a trustworthy supplier of high-quality products and received ISO9001:2008 certification in 2017.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content

4-Cyanobenzoic acid

URL Supplier Web Content
619-65-8
Betrixaban Maleate
Established in 2011 and situated in Hangzhou, Zhejiang, China, Hangzhou Longshine Bio-Tech CO., Ltd is de...
Established in 2011 and situated in Hangzhou, Zhejiang, China, Hangzhou Longshine Bio-Tech CO., Ltd is dedicated to providing services for pharmaceutical and chemical products, catering to both export and import markets. The company consists of two primary business departments: the Professional Sourcing/Product Team and the Quality Team. Backed by experienced partners, Longshine has evolved into a trustworthy supplier of high-quality products and received ISO9001:2008 certification in 2017.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content

5-Methoxy-2-nitrobenzoic acid

URL Supplier Web Content
1882-69-5
Betrixaban Maleate
Established in 2011 and situated in Hangzhou, Zhejiang, China, Hangzhou Longshine Bio-Tech CO., Ltd is de...
Established in 2011 and situated in Hangzhou, Zhejiang, China, Hangzhou Longshine Bio-Tech CO., Ltd is dedicated to providing services for pharmaceutical and chemical products, catering to both export and import markets. The company consists of two primary business departments: the Professional Sourcing/Product Team and the Quality Team. Backed by experienced partners, Longshine has evolved into a trustworthy supplier of high-quality products and received ISO9001:2008 certification in 2017.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY